Microsoft launches new online health record, search service

Share this article:

Microsoft today announced that it has made the leap into the online consumer healthcare space by offering free personal health records on the Web.

The service called HealthVault will offer consumers personal health records and an Internet search engine tailored for health.

“The value of what we're doing will go up rapidly as we get more partners,” Peter Neupert, the vice president in charge of Microsoft's health group, told The New York Times.

Several organizations including Johnson & Johnson, the American Heart Association, LifeScan, NewYork-Presbyterian Hospital, the Mayo Clinic and MedStar Health, a network of seven hospitals in the Baltimore-Washington region, have already signed on for HealthVault-related projects.

Meanwhile last month, Google sought to quell rumors that it is looking to get into the consumer online healthcare space.

“Google is not a healthcare company, nor do we aspire to be one,” product marketing manager Missy Krasner said during a panel discussion at the Health 2.0 User Generated Healthcare conference in San Francisco on Sept. 20.

“We are taking this kind of slowly and have a very modest approach. Right now, our business model is to put out a product that is valuable to users that will help drive search.”

Krasner's comments followed the recent departure of Adam Bosworth, Google's executive in charge of the company's health information push, who parted ways with the company just a few weeks ago to pursue “other interests.”

Bosworth joined Google three years ago from software provider BEA and had been thought to be working on a major new health service at the company.

Google watchers had speculated the new service could also be centered on ways to allow consumers to create breakthrough ways to search for health information online and create their own personal electronic medical records.

Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...